Home > Search Results

Results: 8

Interventions for metabolic bone disease in children with chronic kidney disease

Chronic kidney disease (CKD) resulting in reduced kidney function and the need for dialysis and kidney transplant is associated with abnormalities in serum calcium and phosphorus levels leading to high levels of the parathyroid hormone (PTH) and to bone disease. This may result in bone deformities, bone pain, fractures and reduced growth rates. Commonly used treatments (vitamin D compounds and phosphate binders) aim to prevent or correct these outcomes. However, these treatments may raise levels of blood calcium, allow calcium and phosphorus deposition in blood vessels and lead to early cardiovascular disease, which is known to be a problem in adults with CKD.

Cochrane Database of Systematic Reviews: Plain Language Summaries [Internet] - John Wiley & Sons, Ltd.

Version: 2015

Phosphate binders for preventing and treating bone disease in chronic kidney disease patients

People with chronic kidney disease (CKD) develop impaired excretion of the dietary phosphorus. This results in a condition known as mineral and bone disorder in chronic kidney disease (CKD‐MBD). CKD‐MBD is characterized by high bone turnover, increased musculoskeletal morbidity including bone pain and muscle weakness, and vascular calcification which may contribute to the high incidence of cardiovascular disease and associated deaths. Several agents such as phosphate binders, vitamin D compounds, and calcimimetics are widely used to slow the development and progression of CKD‐MBD complications.

Cochrane Database of Systematic Reviews: Plain Language Summaries [Internet] - John Wiley & Sons, Ltd.

Version: 2011

Chinese herbal medicines for osteoporosis

We conducted a review of the effects of Chinese herbal medicines for people with primary osteoporosis. We found 108 studies with 10,655 people.

Cochrane Database of Systematic Reviews: Plain Language Summaries [Internet] - John Wiley & Sons, Ltd.

Version: 2014

Drugs for reducing stomach acid for people with cystic fibrosis

We reviewed the evidence for using drugs to reduce stomach acid in people with cystic fibrosis.

Cochrane Database of Systematic Reviews: Plain Language Summaries [Internet] - John Wiley & Sons, Ltd.

Version: 2016

Prostate Cancer, Nutrition, and Dietary Supplements (PDQ®): Patient Version

Expert-reviewed information summary about the use of nutrition and dietary supplements for reducing the risk of developing prostate cancer or for treating prostate cancer.

PDQ Cancer Information Summaries [Internet] - National Cancer Institute (US).

Version: February 2, 2017

Sucroferric oxyhydroxide (Velphoro) for chronic kidney disease: Overview

Sucroferric oxyhydroxide (trade name: Velphoro) has been approved in Germany since August 2014 for treating chronic kidney disease in adults by regulating phosphate levels.

Informed Health Online [Internet] - Institute for Quality and Efficiency in Health Care (IQWiG).

Version: January 2, 2015

Are changes to diet effective to manage mineral and bone abnormalities in people with chronic kidney disease?

Problems with mineral and bone metabolism are very common in people with chronic kidney disease (CKD) which can lead to broken bones (fracture), heart and blood circulation (cardiovascular) problems, and sometimes death. Many pharmaceutical treatments used to treat mineral‐bone disease can have side effects and cause problems for patients. We wanted to find out if specific diets (such as low protein or phosphorus intake) were better or worse than normal diets or pharmaceutical treatments.

Cochrane Database of Systematic Reviews: Plain Language Summaries [Internet] - John Wiley & Sons, Ltd.

Version: 2016

Treating kidney stones

Small kidney stones often pass on their own and don't need treatment as long as they don't cause any severe pain or complications. Larger kidney stones usually need to be removed. Depending on how large the kidney stones are and where they're located, they can be destroyed, removed using endoscopy or operated on.Kidney stones with a diameter of less than 5 millimeters pass on their own 70% of the time, and stones that are between 5 and 10 millimeters are flushed out in about 50% of cases. The amount of time this takes varies greatly. Small kidney stones are often passed in your urine after one or two weeks.If a stone is expected to be flushed out with your urine without any treatment, it's usual to simply wait. Anti-inflammatory painkillers like diclofenac can provide relief if the kidney stone causes pain as it travels through the ureter.Larger stones will usually have to be broken up or surgically removed. This needs to be done in the following instances:The kidney stone isn't passed within four weeks.There are complications.It causes severe renal colic.The stone is larger than 10 mm in diameter.Uric acid stones can sometimes be dissolved using medication.

Informed Health Online [Internet] - Institute for Quality and Efficiency in Health Care (IQWiG).

Version: February 25, 2016

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...